A headline about killing cancer cells can sound like a treatment result. Before reading it that way, check whether the experiment involved people, animals or cells in a dish.
Which cells were tested?
The 2014 study tested PNC-27 against p53-null K562 leukemia cells, with murine leukocytes and PNC-29 as controls. Researchers examined membrane HDM-2, peptide colocalization, LDH release and caspase-3/7 activity.
What did “nearly 100%” describe?
The authors reported nearly complete killing of the tested K562 cells under the experimental conditions, with LDH release supporting membrane damage. They did not report killing of the leukocyte comparison cells. The abstract does not provide enough detail to turn that headline percentage into a transferable concentration-and-time protocol.
Why use more than one measurement?
A count can show that cells were lost. A separate measurement asks how that happened. The membrane-damage and caspase checks help distinguish possible explanations rather than treating every decrease in cell number as the same event.
Controls matter for another reason: they show what the test is being compared with. A comparison peptide helps assess specificity within the experiment. A different cell type asks a different question. Neither control by itself represents every healthy tissue in a person.
What the result does not establish
This was not a leukemia treatment trial. It cannot give a patient response rate, a survival benefit or a safe clinical regimen. A human cell line can be useful for studying a mechanism while still being far removed from a whole person.
How to describe the research accurately
A clear description names the cell line, the measured damage signal and the controls. “PNC-27 showed activity against K562 cells in this experiment” preserves the useful finding. “PNC-27 treats leukemia” skips evidence the experiment did not supply.
For laboratory replication, consult the original methods before choosing an exposure or endpoint. Keep the complete sequence and material records attached to the assay plan.
Related NHD research material
The NHD PNC-27 product page identifies related laboratory catalog options. For a material enquiry, specify the exact identity, quantity, planned assay and required analytical records. Published results do not validate an NHD batch.
Ask NHD about material options and available documents.
Original research
PNC-27 induces necrosis in poorly differentiated leukemia cells expressing membrane HDM-2; 2014. Sources checked 10 October 2026.
AI-assisted editorial review checked study numbers, wording and product links; this is not independent peer review. NHD catalog materials are for laboratory research, development and manufacturing, not human or veterinary use. A catalog material is not a clinical trial medicine or a tested finished formulation.
Sources & editorial method
AI-assisted writing
1 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
AI-assisted source and readability checks, not independent peer review.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
Primary records and authoritative sources
Continue with structured records
Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.
